Find Academic Supervisors

ABDULLAH AKPOLATView profile

Associate Professor

• Mechanical Engineering
• Machine Design and Machine Elements
• Finite Element Analysis
• +4 more

Associate Professor Abdullah Akpolat is affiliated with Gaziantep University in the Faculty of Engineering, Department of Mechanical Engineering . He has been active in academic roles since 1983, with a focus on Machine Design and Machine Elements in mechanical engineering. PhD in Mechanical Engineering (1997) from Gaziantep University Master’s degree in Mechanical Engineering (1988) from Middle East Technical University Bachelor’s in Mechanical Engineering (1983) from Middle East Technical University His research explores gear design , finite element analysis , and composite materials , with a particular emphasis on reducing stress in mechanical components. His recent work includes graphene nanoplatelet applications in hybrid composites and dual asymmetry in gear tooth profiles. Abdullah Akpolat has published extensively on spur gears, asymmetric tooth design, and thermophysical properties of construction materials. His work intersects machine design , finite element modeling , and material science , with collaborations across Turkey and international institutions. He has received TUBITAK Publication Encouragement Awards in 2015 and 2018. His academic career includes leadership roles such as Deputy Head of Department and Faculty Board Membership . Advised PhD and Master’s theses on gear stress analysis, torque coupling design, and composite optimization Managed research projects on asymmetric gears, semi-active suspension, and olive oil production systems Contributed to industry through ÇİLTUĞ Heating Industry Trade Inc. (1984–1986)

MEHMET ŞAHİNView profile

Professor

• Cancer Biology
• Epigenetics
• Immunology
• +5 more

Professor MEHMET ŞAHİN serves at Gaziantep University Faculty of Medicine, Department of Basic Medical Sciences since 2019, having previously held Associate Professor positions at Kahramanmaraş Sütçü İmam University (2015-2018) and Akdeniz University (2012-2015). His academic journey includes a Doctorate in Medical Biochemistry from Akdeniz University (2003-2009) and Master's degree in the same field (2000-2003), following undergraduate studies in Biology at Hacettepe University. Doctorate: Medical Biochemistry, Akdeniz University (2003-2009) Master: Medical Biochemistry, Akdeniz University (2000-2003) Bachelor: Biology, Hacettepe University (1995-1999) His research spans cancer biology with focus on angiogenesis, epigenetic regulation of immune responses, and neuropathic pain mechanisms. Key interests include tumor microenvironment interactions, DNA methylation effects on T-cell differentiation, oxidative stress in chemotherapy toxicity, and therapeutic applications of pulsed magnetic fields. His work bridges molecular oncology with translational immunology, particularly examining how epigenetic modifiers influence cancer progression and treatment resistance. Analysis of his 15 most recent publications reveals strong emphasis on angiogenesis modulation in cancer therapy (38%), neuropathic pain mechanisms (27%), and epigenetic regulation of immune responses (20%), with emerging work on electromagnetic field applications in inflammation control (15%). His research consistently connects molecular mechanisms with therapeutic interventions across oncology and neuroimmunology. Professional Associations Congress Poster First Prize (Turkish Biophysics Association, 2019) Professor ŞahİN has supervised four Master's theses and one Doctoral thesis while managing 11 research projects totaling approximately 2.5 million TRY in funding, including TÜBİTAK and university-supported initiatives. His projects span cancer biomarker discovery, neuropathic pain mechanisms, and epigenetic immunomodulation. He has served as coordinator for medical education programs and as Deputy Director of the Biomedical Application and Research Center at Kahramanmaraş Sütçü İmam University, where he also chaired ethics committees for animal experiments.

• Biomedical Sensors
• Diagnostic Devices
• Biosensors
• +6 more

James Davis is Professor of Biomedical Sensors in the School of Engineering at Ulster University and a member of the Engineering Research Institute. He holds BSc and PhD degrees in Chemistry from the University of Paisley and has Chartered Chemist status from the Royal Society of Chemistry since 1996. As a Senior Fellow of the Higher Education Academy, he teaches Engineering Fundamentals, Physical Sciences 2, Professional Skills and Advanced Medical Sensors. His research focuses on developing diagnostic devices for rapid disease and injury treatment, with expertise in biomedical sensors, particularly for ostomy management, wound monitoring, and early cancer detection. His work spans material science, electrochemistry, and medical device development, with significant contributions to smart implants, transdermal micro-devices, and autonomous drug delivery systems. Analysis of his recent publications shows a strong trend toward practical clinical applications, with emphasis on non-invasive monitoring technologies, infection detection systems, and patient-centered medical devices that address real healthcare challenges. His research increasingly integrates wireless connectivity and data analytics with traditional sensor technologies. Member of the Royal Society of Chemistry Senior Fellow of the Higher Education Academy Chartered Chemist since 1996 Principal Investigator on multiple EPSRC-funded projects Professor Davis actively supervises research students and collaborates with industry partners to commercialize his sensing technologies. His work bridges fundamental material science with practical clinical applications, particularly in wound management and ostomy care. He leads several research teams focused on developing next-generation medical sensors and has established strong international collaborations with institutions including the University of Connecticut and National University of Ireland Galway.

• Neurogenetics
• Mitochondrial Diseases
• Hereditary Ataxias
• +4 more

Carlo Casali is an Associate Professor in the Department of Medical-Surgical Sciences and Biotechnologies at Sapienza University of Rome's Faculty of Medicine and Pharmacy. His career spans over three decades in neurology with specialized expertise in neurogenetics, mitochondrial disorders, and hereditary ataxias. He directs the Neurogenetics Outpatient Clinic and coordinates the Neurological Diseases Course at the Latina campus. His research focuses on molecular mechanisms of neurodegenerative disorders, particularly mitochondrial cardiomyopathies, Friedreich's ataxia, and hereditary spastic paraplegias. Casali pioneered the characterization of mitochondrial DNA mutations (A4300G, G8363A) and developed the hematopoietic stem cell transplant protocol for MNGIE. His current work integrates AI-driven gait analysis with exoskeleton rehabilitation for cerebellar ataxia. Casali's publication portfolio includes 118 papers (h-index 20, 1140 citations), with recent work emphasizing biomarker discovery and digital phenotyping. His research is supported by Telethon Foundation grants and national projects including the SPG4 epidemiology study. He actively collaborates with Columbia University's Neurology Department, maintaining a 30-year research partnership. As an educator, he coordinates multiple degree programs including Physiotherapy at Latina and teaches Neurology across medical and healthcare curricula. His clinical work bridges molecular diagnostics with patient-centered rehabilitation, focusing on improving functional outcomes in rare neurological disorders.

Oleksandr Ivanovych VorobetsView profile

Associate Professor

• Semiconductor Devices
• Signal Processing
• Control Systems
• +3 more

Oleksandr Ivanovych Vorobets serves as an Associate Professor in the Department of Computer Systems and Networks at Chernivtsi National University. He holds the academic degree of Candidate of Physical and Mathematical Sciences, awarded for his 2007 PhD thesis on modifying metal-chalcogenide semiconductor barrier structures using pulsed laser irradiation. His academic foundation was built at Yuriy Fedkovych Chernivtsi State University, where he graduated from the Faculty of Physics, Department of Microelectronics and Semiconductor Devices. Research interests span semiconductor device physics , signal processing , and computer engineering , with a focus on modeling and algorithmizing primary information signal converters based on semiconductor barrier structures. His work integrates laser processing techniques for manipulating structural defects in semiconductors and developing hardware/software systems for instrumentation and control. Analysis of his publication history reveals two distinct phases: early work (2003-2009) concentrated on semiconductor material science and laser defect engineering in cadmium telluride structures, while recent publications (2015-2018) pivot toward cryptographic hardware design for IoT and telemetry applications, featuring reconfigurable coprocessors and stream ciphers. Vorobets instructs core computer engineering courses including Computer Electronics, Computer Circuit Engineering, Computer Architecture, System Programming, Microcontrollers, and Automation of Technological Processes and Measurements. His email contact is o.vorobets@chnu.edu.ua.

• Epidemiology
• Nutrition
• Neurology
• +3 more

Alberto Ascherio is an Italian-American physician, epidemiologist, and nutritionist serving as Professor of Epidemiology and Nutrition at Harvard T.H. Chan School of Public Health and Professor of Medicine at Harvard Medical School. His career centers on neurodegenerative disease research using large-scale longitudinal cohort studies across global populations. He earned his Doctor of Medicine and Surgery from the University of Milan (1978) followed by Master of Public Health (MPH) and Doctor of Public Health (DrPH) degrees from Harvard University after medical practice in Africa and Latin America. Ascherio's research integrates epidemiology, nutrition, and neurology to investigate environmental triggers of neurological disorders. He pioneered the causal link between Epstein-Barr virus and multiple sclerosis, demonstrated vitamin D's role in MS progression, and identified dietary flavonoids as protective factors against Parkinson's disease through rigorous analysis of cohort data. His publication trends reveal a strategic focus on infectious etiologies of neurodegeneration and nutritional interventions, with landmark studies in Science, JAMA, and Neurology establishing new paradigms for understanding MS and Parkinson's disease mechanisms. His scientific recognition includes: 2025 Breakthrough Prize in Life Sciences (shared with Stephen L. Hauser) for establishing Epstein-Barr virus as the primary causal factor in multiple sclerosis Ascherio directs research within major longitudinal frameworks including the Nurses' Health Study, Health Professionals Follow-up Study, and Scandinavian cohorts from Denmark and Finland. His team leverages decades of biomarker and lifestyle data to identify modifiable risk factors for neurodegenerative diseases, with current work expanding into viral immunology and precision nutrition approaches.

Neslihan OflazView profile

Lecturer

• Cosmology
• Theoretical Physics
• Modified Gravity
• +3 more

Neslihan Oflaz is a Lecturer at the Department of Mathematics, Faculty of Arts and Sciences, Yeditepe University. With a dual academic background in Mathematics and Physics, she holds a PhD in Physics from Koç University (2015) and a Bachelor's degree in Mathematics from Middle East Technical University (2007), complemented by a Physics minor (2006). PhD: Koç University, Physics (2015) Master's: Koç University, Physics (2009) BSc: Middle East Technical University, Mathematics (2007) Physics Minor: Middle East Technical University (2006) Her research focuses on cosmology and modified gravity theories, particularly analyzing accelerated expansion models and anisotropic cosmologies through Brans-Dicke gravity and higher-dimensional frameworks. She has contributed to nonlinear optical phenomena studies and geometric scattering problems. Recent publications explore nonlinear permittivity effects in Kerr slabs, incoherent nonlinearity in optical systems, and geometric constraints on particle motion. These works reflect her interdisciplinary approach bridging mathematical physics and cosmology. Full Scholarship, Koç University PhD program Dr. Oflaz teaches undergraduate and graduate courses in mathematics, including Linear Algebra, Differential Equations, Discrete Mathematics, and senior project seminars. She combines theoretical physics insights with mathematical rigor in her pedagogy.

Angela GrittiView profile

Associate Professor

• Regenerative Medicine
• Gene Therapy
• Neural Stem Cells
• +7 more

Angela Gritti is an Associate Professor of Human Histology at Vita-Salute San Raffaele University and a Group Leader at the San Raffaele Telethon Institute for Gene Therapy (SR-TIGET) since 2006. Her work focuses on genetic neurodegenerative diseases , particularly Leukodystrophies and GM2 gangliosidosis , using neural stem cells and gene therapy approaches. PhD in Basic Sciences and Veterinary Biotechnology (University of Turin, 2006) Specialty in Toxicology (University of Milan, 1996) Degree in Biological Sciences (University of Milan, 1990) Her research explores regenerative medicine and gene therapy through neural stem cell biology , focusing on: Pathogenesis of lysosomal storage disorders iPSC modeling of human CNS diseases AAV/lentiviral vector safety Epigenetic modulation of oligodendrocytes Preclinical development for metabolic CNS diseases The articles section reveals her contributions to gene therapy safety , iPSC neural modeling , and combined cell/gene strategies for leukodystrophies. Despite extensive grant reviewer roles (ERC, AFM Telethon, EJPRD) and international collaborations with institutions in France, Norway, and the USA, no formal scientific awards are listed in the current text. She has supervised 12 PhD students and 22 master's students while leading funded projects with institutions like the Bespoke Gene Therapy Consortium (NIH), European Leukodystrophy Association , and Italian Telethon Foundation . Her lab also contributes to patient advocacy through educational outreach and clinical translation frameworks.

Paola Panina-BordignonView profile

Associate Professor

• Immunology
• Neuroscience
• Cell Biology
• +5 more

Paola Panina-Bordignon is an Associate Professor in Applied Medical Sciences at the Faculty of Medicine, Vita-Salute San Raffaele University, Milan. She also works as a Scientist in the Division of Neuroscience at Ospedale San Raffaele, leading international research networks like BRAVEinMS focused on progressive multiple sclerosis (MS) drug discovery. Ph.D. in Cellular and Molecular Biotechnologies, Università degli Studi di Brescia Post-graduate Specialisation in Microbiology, summa cum laude, Università degli Studi di Parma Master Degree in Biological Sciences, summa cum laude, Università degli Studi di Parma Her research integrates cell biology, immunology, and neuroscience to study immune-mediated central nervous system (CNS) disorders. She focuses on neuroimmunology, neuroprotective stem cell therapies, and virology-related neurodegeneration, with publications spanning multiple sclerosis, Zika virus effects on neural cells, and epigenetic mechanisms. Scientific awards include the Royan International Research Award (2013) and fellowships from the Association pour la Recherche sur le Cancer and Istituto Superiore di Sanità (both in 1991). She supervises research projects on neurogenic iPSC-derived neural progenitor cells and their therapeutic applications, and actively participates in gender studies and equal opportunities initiatives at her university.

• Musculoskeletal Health
• Adolescent Health
• Pain Management
• +3 more

Maren Hjelle Guddal serves as a Postdoctoral Fellow at Oslo Metropolitan University's Department of Rehabilitation Science and Health Technology within the Faculty of Health Sciences. Her research centers on developing person-centered interventions to address persistent pain and disability in adolescent populations. Education: Physiotherapy Degree, Western Norway University of Applied Sciences (2006) Master's in Sports Physiotherapy, Norwegian School of Sport Sciences (2011) PhD, University of Oslo (2021) Research Focus: Dr. Guddal investigates critical intersections between physical activity, sport participation, musculoskeletal pain, and mental health in adolescents. Her work identifies modifiable risk factors for conditions like obesity and neck pain while pioneering co-developed interventions with end-users. Current emphasis targets translational pathways from epidemiological findings to clinical pain management solutions. Publication Trends: Her 2016-2023 publications reveal evolving expertise from foundational epidemiological studies on adolescent pain and sports injuries toward contemporary intervention development. Recent work demonstrates methodological progression from observational cohort analyses (HUNT/Young-HUNT studies) to pilot RCT frameworks for persistent pain management. Current Initiative: She leads the HEYoung intervention study, collaborating with adolescents, parents, and healthcare providers to co-design and pilot-test a person-centered intervention for adolescent persistent pain, preparing for full-scale randomized controlled trials. Research Context: Embedded within OsloMet's Musculoskeletal Health Research group, her work bridges clinical physiotherapy practice with population health research, leveraging prior experience from Oslo University Hospital's FORMI unit. Professional Context: With background as a practicing physiotherapist in primary/secondary care, she maintains strong clinical connections while advancing evidence-based rehabilitation science through rigorous academic research.

Mark SmitsView profile

Researcher

• Endocrinology
• Metabolism
• Gut Hormone Physiology
• +5 more

Mark Smits is a postdoctoral researcher at the University of Copenhagen's Faculty of Health and Medical Sciences, Department of Biomedical Sciences, working within Professor Jens Juul Holst's research group focused on endocrinology and metabolism. His academic journey began with medical training in Amsterdam where he earned both Bachelor's and Master's degrees with honors from Vrije Universiteit Amsterdam. Medical Doctor (MD) qualification from Amsterdam PhD in gut-hormone based therapies from Vrije Universiteit Amsterdam (completed with honors) Current endocrinology specialist training Dr. Smits' research centers on gut hormone physiology, particularly mechanisms to enhance glucagon-like peptide-1 (GLP-1) secretion. His work spans molecular mechanisms of hormone secretion, dietary influences on metabolic pathways, and therapeutic applications for diabetes and metabolic disorders. Recent publications demonstrate expertise in incretin biology, gut-brain axis signaling, and translational approaches to metabolic disease. His collaborative research network spans multiple international institutions, with significant contributions to understanding GLP-1 secretion pathways, nutrient-hormone interactions, and metabolic adaptations in disease models. Dr. Smits has published over 65 peer-reviewed articles, with recent work appearing in high-impact journals including Diabetes , American Journal of Physiology , and Diabetes/Metabolism Research and Reviews . As part of Holst's renowned research group, he contributes to cutting-edge investigations into gut hormone-based therapies while advancing his clinical training in endocrinology. His dual expertise in clinical medicine and basic research positions him at the intersection of translational endocrinology and metabolic disease therapeutics.

• Textile Engineering
• Nanomaterials
• Photocatalysis
• +5 more

Jose Heriberto Oliveira do Nascimento is an Associate Professor in the Department of Textile Engineering at the Federal University of Rio Grande do Norte (UFRN), Brazil, where he has been employed since February 2013. He also serves as the Coordinator of the Graduate Program in Chemical Engineering (since March 2022) and previously held the position of Department Head for Textile Engineering (from April 2019). Dr. Nascimento earned his PhD in Textile Engineering from the University of Minho, Portugal in 2012, following a Master's degree in Mechanical Engineering and a Bachelor's degree in Textile Engineering, both from UFRN. His research spans multiple interdisciplinary fields at the intersection of textile engineering, nanotechnology, and environmental applications. His research interests focus on advanced materials development, particularly in nanomaterials synthesis and application, photocatalysis for environmental remediation, graphene and carbon-based nanomaterials, electrochemical sensors, sustainable polymer composites, and innovative textile processing techniques. His work demonstrates a strong commitment to developing environmentally friendly solutions for industrial challenges. Analysis of his recent publications (2023-2025) reveals a research trajectory centered on sustainable materials development, environmental remediation technologies, and advanced nanomaterial applications. His work spans energy conversion (solar cells), environmental protection (wastewater treatment), healthcare (wearable sensors), and sustainable manufacturing (eco-friendly textile processing), demonstrating a multidisciplinary approach to solving complex engineering challenges. Dr. Nascimento has served as a peer reviewer for numerous prestigious journals including Carbohydrate Polymers, Cellulose, Chemistry of Materials, Colloids and Surfaces, Journal of Drug Delivery Science and Technology, and Journal of Solid State Electrochemistry, indicating his recognition as an expert in his field. His academic contributions extend beyond research to educational leadership through his coordination of graduate programs and departmental administration, reflecting his commitment to advancing both knowledge and academic infrastructure in his field.

• Nephrology
• Hereditary Renal Diseases
• Alport Syndrome
• +3 more

Martin C. Gregory, DPhil, MBChB is a Clinical Professor of Medicine at the University of Utah School of Medicine, specializing in the Department of Internal Medicine's Nephrology & Hypertension division. His clinical expertise encompasses general nephrology and hereditary renal diseases, with particular focus on Alport Syndrome and related collagen disorders. Dr. Gregory received his BM, BCh and DPhil Degrees (MD, PhD equivalents) from Oxford University. His medical training continued with residency at the University of London and Oxford University, followed by fellowship in nephrology at Oxford University. He also received additional nephrology training at the University of Paris (VI) and training from the University of Otago in New Zealand. Dr. Gregory is board certified in both Internal Medicine and Nephrology by the American Board of Internal Medicine. Dr. Gregory's research has primarily focused on hereditary renal diseases, particularly Alport Syndrome. His work spans genetic aspects of the disease, clinical manifestations across different organ systems (including renal, ocular, and auditory), diagnostic approaches, and management strategies. He has made significant contributions to understanding genotype-phenotype correlations in X-linked Alport Syndrome and has been instrumental in developing clinical guidelines for genetic testing and management of this condition. His publication record demonstrates a consistent focus on Alport Syndrome over several decades, with recent work addressing molecular diagnostics, genetic modifiers, and ocular manifestations of the disease. Dr. Gregory has also contributed to broader nephrology topics including dialysis accessibility in developing countries and thin basement membrane nephropathy. Dr. Gregory has held significant leadership positions including Chief of Nephrology at Groote Schuur Hospital in Cape Town, South Africa, and Director of Dialysis Services at the Bermuda Hospitals Board. He currently serves on the Medical Advisory Boards of both the Alport Syndrome Foundation and the National Kidney Foundation of Utah and Idaho, demonstrating his commitment to patient advocacy and clinical guidance in his specialty areas.

Francis JohnsonView profile

Professor

• Stereochemistry
• Natural Product Synthesis
• DNA Damage and Repair
• +6 more

Francis Johnson is a Professor of Pharmacological Sciences at Stony Brook University's Renaissance School of Medicine, with a joint appointment in the Department of Chemistry. He has been a faculty member since November 1973, following a research position at The Dow Chemical Company's Eastern Research Laboratory. Dr. Johnson obtained his B.Sc. and Ph.D. degrees from Glasgow University in Scotland, followed by postdoctoral training at Boston University in the laboratory of Walter Gensler. Dr. Johnson's research spans four major areas: stereochemistry (where he developed the influential "Allylic Strain" theory), natural product synthesis (including cycloheximide, bleomycin, and prostaglandins), DNA damage and repair chemistry, and more recently, the chemistry of diseases of aging. His work on DNA adducts has been particularly significant, where he devised methods to introduce damage from carcinogens into DNA. His recent research focuses on Aristolochic Acids and developing drugs to prevent collagen loss in aging-related diseases. He's currently involved in five drug development projects, including LB-100 (a cancer drug) and CMC 2.24 (for periodontitis and osteoarthritis). His publications show a clear trend toward translational research, particularly in the last decade. He has shifted from fundamental chemistry research to drug development, with a focus on anti-aging compounds that prevent collagen loss. His recent work on chemically-modified curcumin derivatives shows promise for treating periodontitis, osteoarthritis, and diabetic wound healing. Dr. Johnson has made significant contributions to science, with his work on "Allylic Strain" being one of the most quoted papers in organic chemistry history. His drug development efforts have resulted in LB-100 passing clinical trials successfully, with the company developing it expected to list on NASDAQ. CMC 2.24 is being licensed to a French veterinary company for use in companion animals, with potential for human therapy due to its lack of demonstrable side effects. Dr. Johnson has mentored numerous students and researchers throughout his career, though specific names aren't provided in the available information. His work has been supported by various grants focused on DNA damage, drug development, and aging-related diseases. He has published nearly 400 papers and patents throughout his career. Dr. Johnson leads research teams focused on drug synthesis and development, particularly for compounds targeting aging-related diseases. His laboratory has developed innovative methods for synthesizing DNA adducts and creating novel drug candidates that prevent collagen loss in diseases of aging.

• Chemical Biology
• Cancer Metabolism
• Epigenetics
• +7 more

Jordan L. Meier, Ph.D. is a Senior Investigator and Head of the Epigenetics and Metabolism Section at the Chemical Biology Laboratory within the Center for Cancer Research at the National Cancer Institute, National Institutes of Health. His research bridges chemical biology, cancer metabolism, and epigenetic regulation, focusing on how metabolic states influence genomic signaling through chromatin modifying enzymes. Dr. Meier's educational background includes: Bachelor's degree in Chemistry from Creighton University (2004) Ph.D. in Chemistry from University of California-San Diego (2009), working under Professor Michael D. Burkart Postdoctoral training as an American Cancer Society fellow at California Institute of Technology with Professor Peter B. Dervan His research interests center on the intersection of metabolism and epigenetics, particularly how metabolic perturbations influence epigenetic signaling. Dr. Meier's laboratory develops chemical approaches to investigate metabolic and epigenetic signaling pathways in cancer, with special focus on acetyl-CoA mediated acetylation mechanisms and oncometabolite-driven cancers. His work aims to discover biological mechanisms underlying oncometabolite-driven cancers, develop new cancer diagnostics, and identify small molecules that inhibit epigenetic modifications through metabolic disruption. Analysis of Dr. Meier's publications reveals a consistent research trajectory exploring the chemical biology of metabolic-epigenetic crosstalk. His work spans from fundamental chemical probe development to cancer-relevant biological applications, with particular emphasis on acetylation-based signaling mechanisms, oncometabolite detection, and chemoproteomic mapping of metabolic enzyme targets. His research has significantly advanced understanding of how metabolites like fumarate and acyl-CoA derivatives regulate epigenetic processes in cancer. Notable recognition includes: American Cancer Society postdoctoral fellowship Dr. Meier actively mentors a diverse research team including postdoctoral fellows and postbaccalaureate researchers. His laboratory has developed innovative chemical tools and approaches that have enabled new avenues for understanding metabolic regulation of epigenetic processes. Current research includes development of the Fumarate Chemoproteomic Reactivity Database to enable community efforts in studying FH-regulated cysteines. The Chemical Biology Laboratory fosters a collaborative environment with active participation in symposia and scientific meetings. Dr. Meier's team engages in both fundamental chemical biology research and translational applications, with a particular focus on developing new approaches for cancer therapy, diagnosis, and chemoprevention based on metabolic-epigenetic connections.